You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

wAMD

Showing 51 - 75 of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Canadian Treat and Extend Analysis Trial With Ranibizumab

Completed
  • wetAMD
  • 0.5 mg Ranibizumab intravitreal injections
  • Calgary, Alberta, Canada
  • +23 more
Jun 3, 2020

Age-related Macular Degeneration Trial in Wuhan, Shanghai (Treat-and-Extend regimen, Pro Re Nata, Conbercept)

Unknown status
  • Age-related Macular Degeneration
  • Treat-and-Extend regimen
  • +2 more
  • Wuhan, Hubei, China
  • +4 more
May 17, 2020

Caregiver Burden of Wet Age-related Macular Degeneration in

Completed
  • Wet Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Many Locations, Japan
    (unnamed)
Aug 21, 2017

Polypoidal Choroidal Vasculopathy Trial in Shanghai, Hangzhou, Wenzhou (conbercept, Initial PDT, Delayed PDT)

Completed
  • Polypoidal Choroidal Vasculopathy
  • Shanghai, Shanghai, China
  • +2 more
Jul 17, 2019

Wet Age Related Macular Degeneration Trial in Italy (ranibizumab)

Completed
Has Results
  • Wet Age Related Macular Degeneration
  • Alessandria, AL, Italy
  • +100 more
May 11, 2019

Aflibercept in roUtine Clinical Practice in patientS With Wet

Completed
  • Wet Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Italy
    (unnamed)
Jul 28, 2019

Intraocular Cytokines in Non-responders to Ranibizumab Treatment

Completed
  • Age Related Macular Degeneration
  • Toronto, Ontario, Canada
    Toronto Western Hospital
Oct 9, 2018

Wet Age-Related Macular Degeneration Trial in Germany (Ranibizumab 0.5 mg, Aflibercept 2 mg)

Completed
Has Results
  • Wet Age-Related Macular Degeneration
  • Ranibizumab 0.5 mg
  • Aflibercept 2 mg
  • Koeln, Germany
  • +5 more
Jan 31, 2019

Wet Macular Degeneration Trial in Japan (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

Completed
Has Results
  • Wet Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Ichinomiya, Aichi, Japan
  • +40 more
Dec 20, 2018

Mobile Clinic - a Cross-sectional Epidemiological Survey

Completed
  • Age Related Macular Degeneration
    • Bratislava, Slovakia
      Novartis Slovakia, s.r.o.
    Feb 28, 2017

    Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration Trial in London (Eylea)

    Completed
    • Retinal Pigment Epithelial Detachment Secondary to Age-related Macular Degeneration
    • London, Ontario, Canada
      Ivey Eye Institute
    Feb 15, 2017

    Outcomes in Patients Treated With AflIbercept in Real-life

    Completed
    • Wet Macular Degeneration
    • Aflibercept (Eylea, BAY86-5321)
    • Lund, Sweden
      Many locations
    Oct 26, 2018

    Neovascular Age-related Macular Degeneration Trial in Germany, United Kingdom (Ranibizumab)

    Completed
    Has Results
    • Neovascular Age-related Macular Degeneration
    • Bonn, Germany
    • +27 more
    Feb 8, 2019

    Real Life of Aflibercept in France in Patients Refractory to

    Completed
    • Wet Macular Degeneration
    • Aflibercept (EYLEA, BAY-86-5321)
    • Multiple Locations, France
      (unnamed)
    Jun 29, 2018

    Neovascular Age-related Macular Degeneration of All Subtypes Trial in France (Intravitreal injection)

    Completed
    • Neovascular Age-related Macular Degeneration of All Subtypes
    • Intravitreal injection
    • Creteil, France
    • +9 more
    Nov 18, 2016

    Neovascular Age-related Macular Degeneration Trial in Chengdu (TK001)

    Unknown status
    • Neovascular Age-related Macular Degeneration
    • TK001
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Feb 27, 2018

    China Patients: Long-term Treatment Outcome of Conbercept

    Unknown status
    • Wet Age-related Macular Degeneration (wAMD)
      • Baoji, China
      • +48 more
      Feb 13, 2017

      Wet Macular Degeneration Trial in Austria, Germany, Hungary (BI 144807)

      Completed
      Has Results
      • Wet Macular Degeneration
      • BI 144807
      • Wien, Austria
      • +9 more
      Jun 10, 2016

      (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Germany

      Completed
      • Wet Macular Degeneration
      • Anti-VEGF injections
      • Many Locations, Germany
        (unnamed)
      Sep 11, 2015

      Patterns With Lucentis in Approved Indications

      Completed
      • Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV
        • Tübingen, Germany
          Novartis Investigative Site
        Feb 28, 2017

        Age-Related Macular Degeneration, Retinal Function Trial in Lübeck (Lucentis (Ranibizumab))

        Completed
        • Age-Related Macular Degeneration
        • Retinal Function
        • Lucentis (Ranibizumab)
        • Lübeck, Germany
          University of Luebeck - Department of Ophthalmology
        Apr 7, 2015

        Macular Degeneration Trial in Worldwide (Regorafenib, ophthalmic oily suspension (BAY73-4506), Sham IVT, Ranibizumab)

        Terminated
        Has Results
        • Macular Degeneration
        • Regorafenib, ophthalmic oily suspension (BAY73-4506)
        • +3 more
        • Tucson, Arizona
        • +148 more
        Jul 25, 2016

        Very Low Vision Secondary to Wet Age-related Macular Degeneration Trial in Guangzhou city (Conbercept)

        Unknown status
        • Very Low Vision Secondary to Wet Age-related Macular Degeneration
        • Guangzhou city, Guangdong, China
          Zhongshan Ophthalmic Center,Sun yat-sen University
        Jul 21, 2014

        Existing Anti vascUlar Endothelial Growth Factor in Wet

        Completed
        • Ophthalmology, Macular Degeneration
        • Many Locations, Australia
        • +9 more
        Jan 24, 2014

        iVeness of exIsting Anti-vascular Endothelial groWth Factor

        Completed
        • Macular Degeneration
        • Many Locations, Portugal
          (unnamed)
        Sep 30, 2014